Fractyl Health, Inc. Common Stock (GUTS) Earnings History
Net Loss7 years of earnings data (2019–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Fractyl Health, Inc. Common Stock (GUTS) Earnings Overview
As of June 23, 2026, Fractyl Health, Inc. Common Stock (GUTS) reported trailing twelve-month net income of -$108M, reflecting -14.8% year-over-year growth. The company earned $-1.42 per diluted share over the past four quarters.
Looking at the long-term picture, GUTS's historical earnings data spans multiple years. The company achieved its highest annual net income of -$30M in fiscal 2020.
Fractyl Health, Inc. Common Stock is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NVAX (-$88M net income, 39.2% margin), ELVN (-$99M net income), RNAC (-$152M net income, -4658.6% margin), GUTS has comparable earnings metrics. Compare GUTS vs NVAX →
GUTS Earnings vs Peers
Earnings metrics vs comparable public companies
GUTS Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$141M | -105.2% | -$97M | $-1.86 | - | - |
| 2024 | -$69M | +10.9% | -$94M | $-1.62 | -73864.5% | -100571.0% |
| 2023 | -$77M | -66.0% | -$51M | $-1.98 | -64242.5% | -42363.3% |
| 2022 | -$46M | -19.9% | -$49M | $-1.34 | - | - |
| 2021 | -$39M | -27.1% | -$37M | $-1.12 | - | - |
| 2020 | -$30M | +0.4% | -$29M | $-0.86 | - | - |
| 2019 | -$31M | - | -$30M | $-0.64 | - | - |
Download Data
Export GUTS earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
GUTS — Frequently Asked Questions
Quick answers to the most common questions about buying GUTS stock.
What is GUTS earnings per share (EPS)?
GUTS trailing twelve-month (TTM) diluted EPS is $-1.42, reflecting -14.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is Fractyl Health, Inc. Common Stock's net income?
Fractyl Health, Inc. Common Stock (GUTS) trailing twelve-month net income is $-108M as of 2025. Earnings declined -14.8% year-over-year.
Is GUTS profitable?
GUTS is not currently profitable on a TTM basis, reporting a net loss of $-108M. Net margin is N/A. Investors should monitor for a return to profitability.
What is GUTS's earnings growth rate?
GUTS compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are GUTS's profit margins?
Fractyl Health, Inc. Common Stock net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -744.2%.
Is GUTS growing earnings?
GUTS earnings are declining — EPS fell -14.8% year-over-year. TTM net income dropped to $-108M. This contrasts with the 5-year CAGR of N/A.
What was GUTS's best earnings year?
Fractyl Health, Inc. Common Stock's highest annual net income on record is $-30M, achieved in fiscal year 2020. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were GUTS's earnings last quarter?
GUTS's most recent reported quarter was Q1 2026. Net income was $9M with diluted EPS of $0.12. For a full breakdown of all quarters, see the quarterly earnings table on this page.